2008 - Factores de crecimiento hematopoyético-Dr. A. Biete - GICOR
2008 - Factores de crecimiento hematopoyético-Dr. A. Biete - GICOR
2008 - Factores de crecimiento hematopoyético-Dr. A. Biete - GICOR
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
COMENTARIOS EORTC-GUIDELINES<br />
EORTC GUIDELINES<br />
A DIVERSOS ESTUDIOS<br />
1. Henke et al. ORL. Señalan diversas irregularida<strong>de</strong>s<br />
y que los datos han suscitado controversia y<br />
amplias discusiones (cartas cartas al director, etc.).<br />
Lancet<br />
2. Bokkel et al. (1998). Ovario. Ovario.<br />
13% progresión<br />
(brazo brazo EPO) vs 6% (control). “This was thought to<br />
reflect the higher proportion of patients with stage<br />
II rather than stage III/IV disease in the control<br />
group”. Med. Oncol. Oncol<br />
3. Leyland-Jones Leyland Jones et al (2003) Mama M 1 en QT. Se<br />
interrumpe por mortalidad en brazo EPO. (6% vs<br />
3%).<br />
”The authors comment that this study suffered<br />
problems in <strong>de</strong>sign, conduct and post-trial post trial analysis,
Change language